Literature DB >> 15903132

Dose-response relationship of sublingual nitroglycerin with brachial artery dilatation and change in central and peripheral augmentation index.

James J Oliver, Amie Bowler, Querine Beudeker, Thomas ten Cate, David J Webb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15903132     DOI： 10.1016/j.clpt.2005.01.013

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  3 in total

1.  The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men.

Authors:  Bart J Van der Schueren; Rebecca Blanchard; M Gail Murphy; John Palcza; Inge De Lepeleire; Anne Van Hecken; Marleen Depré; Jan N de Hoon
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

2.  Risk factors for metabolic syndrome independently predict arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal comorbidity.

Authors:  Pajaree Lilitkarntakul; Neeraj Dhaun; Vanessa Melville; Debbie Kerr; David J Webb; Jane Goddard
Journal:  Diabetes Care       Date:  2012-05-29       Impact factor: 19.112

3.  Role of Combining Peripheral with Sublingual Perfusion on Evaluating Microcirculation and Predicting Prognosis in Patients with Septic Shock.

Authors:  Pan Pan; Da-Wei Liu; Long-Xiang Su; Huai-Wu He; Xiao-Ting Wang; Chao Yu
Journal:  Chin Med J (Engl)       Date:  2018-05-20       Impact factor: 2.628
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.